• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Jagsonpal Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 2171.0
  • ISIN : INE048B01035
271.35 -14 (-4.80%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    270.00

  • Today’s High

    288.50

  • Open

    286.85

  • Perv Close

    285.03

  • 52W Low

    139.90

  • 52W High

    328.04

Key Indicators

  • P/E(TTM)

    42.30

  • Mar.Cap (₹Cr.)

    1,805.20

  • Div & Yield %

    0.92

  • Book Value(₹)

    36.07

  • Debt-Equity Ratio

    -4.80

  • AGM Date

    01-Aug-2025

  • EPS

    6.41

  • P/E Ratio

    42.30

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    1,805.20

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    13.31

  • BV (₹)

    36.10

  • Sales( ₹ in Cr.)

    268.72

  • NP (in Cr.)

    39.76

  • NP Var(%)

    77.0

  • Div%

    125.0

  • CPS (₹)

    7.20

  • EPS (₹)

    6.00

  • Traded Value (₹ in Lakhs)

    1,803.87

  • 52 Week High

    328.04

  • 52 Week Low

    139.90

  • Price BSE

    271.0

  • Price NSE

    271.00

  • Market Capital( in Cr.)

    1,803.87

  • P/C Ratio

    37.60

  • P/E Ratio

    45.30

  • Price Vs.BV

    6.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 208.70 236.71 217.58 187.95 158.57 166.83
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 208.70 236.71 217.58 187.95 158.57 166.83
Other Income 9.28 5.73 3.43 4.39 2.53 1.43
Stock Adjustments -3.90 -4.30 -5.61 -5.28 -1.25 -19.42
Total Income 214.08 238.14 215.40 187.06 159.85 148.84
EXPENDITURE :            
Raw Materials 76.08 88.04 83.35 75.50 54.94 53.43
Power and Fuel Cost 0.17 0.29 0.47 0.52 0.64 1.41
Employee Cost 61.80 65.18 57.68 53.98 50.37 46.61
Other Manufacturing Expenses 0.73 0.52 0.91 0.48 0.45 0.73
Selling and Administration Expenses 41.09 41.66 42.50 31.88 38.34 32.23
Miscellaneous Expenses 1.87 6.03 2.05 1.22 4.04 3.66
Employee Benefit Expenses 61.80 65.18 57.68 53.98 50.37 46.61
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 181.74 201.72 186.95 163.59 148.79 138.07
Operating Profit 32.34 36.42 28.46 23.47 11.05 10.77
Interest 0.81 0.41 0.29 0.51 0.51 0.75
Gross Profit 31.53 36.01 28.17 22.96 10.54 10.02
Depreciation 1.66 1.21 1.53 1.09 1.13 1.02
Profit Before Tax 29.87 34.80 26.64 21.87 9.41 9.00
Current Tax 7.56 7.63 7.40 6.05 1.57 1.85
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.15 0.46 0.38 -1.23 -0.03 -0.07
Reported Net Profit 22.46 26.72 18.86 17.06 7.87 7.22
Extraordinary Items 0.00 -1.89 0.50 0.00 -0.02 0.00
Adjusted Net Profit 22.46 28.61 18.36 17.06 7.89 7.22
Adjustment below Net Profit 0.29 -1.56 3.95 -3.54 0.00 0.00
P & L Balance brought forward 94.54 69.37 58.59 47.69 41.13 34.71
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 13.10 0.00 12.02 2.62 1.31 0.79
P & L Balance carried down 104.19 94.54 69.37 58.59 47.69 41.13
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 100.00 100.00 80.00 20.00 10.00 5.00
Dividend Per Share(Rs) 5.00 5.00 4.00 1.00 0.50 0.25
Earnings Per Share-Unit Curr 8.50 10.20 7.20 6.51 3.00 2.75
Earnings Per Share(Adj)-Unit Curr 3.40 4.08 2.88 2.60 1.20 1.10
Book Value 70.88 60.65 50.68 43.55 39.39 36.89
Book Value(Adj)-Unit Curr 28.35 24.26 20.27 17.42 15.76 14.76

Shareholding Pattern

  • Promoter Group

    67.65%

  • Public Share Holding

    32.35%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 22,920,800 34.45 22,920,800 2
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 5,717,950 5,717,950.00 5,717,950 5,717,950
Sub Total 28,638,750 43.05 28,638,750 3
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 13,335,635 20.05 13,335,635 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,030,400 4.56 3,030,400 1
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 16,366,035 24.60 16,366,035 2
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 2,000 0.00 1,500 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,449,754 2.18 1,449,754 11
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 31,314 0.05 31,314 2
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 1,483,068 2.23 1,482,568 15
2] Non Institution
Bodies Corporate 1,692,670 2.54 1,690,470 114
Clearing Members 17,178 0.03 17,178 19
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 362,953 0.55 362,953 322
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 801,646 1.21 801,646 397
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 5,965,676 8.97 5,965,676 9
Individuals holding nominal share capital up to Rs. 1 lakh 10,173,177 15.29 9,694,448 22,016
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 5,000 0.01 5,000 1
Others 1,020,327 1.53 1,020,327 1
Sub Total 20,038,627 30.12 19,557,698 22,879
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 66,526,480 100.00 66,045,051 22,899

Company Background

Jagsonpal Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Jagsonpal Pharmaceuticals Ltd
  • BSE Code : 2171.0
  • ISIN : INE048B01035

  • Incorporation Year

    1978

  • Registered Office

    T-210 J
    Shahpur Jat, New Delhi,
    New Delhi-110049

  • Telephone

    91-011-46181100/46109900

  • FAX

    91-011-26498341

  • Chairman

    Harsha Raghavan

  • Managing Director

    Manish Gupta

  • Company Secretary

  • Auditor

    Walker Chandiok & Co LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MCS Ltd
    F-65 1st Floor,
    Okhla Industrial Are,Phase-I
    Mumbai - New Delhi-110020

Jagsonpal Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Jagsonpal Pharma 271.15 217.98 208.70 29.67 16.89
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10